<DOC>
	<DOCNO>NCT01653808</DOCNO>
	<brief_summary>The purpose study compare efficacy biocompatibility Nipro Elisio 210H dialyzer two dialysis modality , conventional hemodialysis line hemodiafiltration .</brief_summary>
	<brief_title>In Vivo Evaluation Nipro Elisio™ Dialyzer</brief_title>
	<detailed_description>Hemodiafiltration , convective-based therapy combine diffusive convective transport appear treatment modality choice hemodialysis patient . Indeed , innovative technique offer effective dialysis modality remove spectrum uremic solute optimize biocompatibility extracorporeal circuit obtain use ultrapure dialysis sterile substitution fluid . However , therapy propose dialysis center due major drawback technique conventional hemodialysis , complexity system increase cost . Alternatively , enhancement convective transport may achieve use innovative dialyzer allow internal filtration . This case ELISIO™-H dialyzer posse fiber great internal length potentially allow internal filtration . Aim present study therefore evaluate efficacy biocompatibility internal filtration-enhanced hemodialysis use dialyzer compare hemodiafiltration , four-month period .</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<criteria>CKD dialysis patient treatment three time week HD three month stable anticoagulation scheme haemoglobin level &gt; 10.5 g/dL vascular access allow stable blood flow 300 mL/min treatment patient already enrol another study pregnancy symptom sign acute/chronic inflammatory infectious disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2008</verification_date>
	<keyword>CKD dialysis</keyword>
	<keyword>hemodialysis</keyword>
	<keyword>hemodiafiltration</keyword>
	<keyword>Elisio dialyzer</keyword>
	<keyword>efficacy</keyword>
	<keyword>biocompatibility</keyword>
</DOC>